Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease

E-ISSN： 2047-9980|4|12|JAHA.115.002321-JAHA.115.002321

ISSN： 2047-9980

Source： JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol.4, Iss.12, 2015-12, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS)

By Raikou M. McGuire A. Colhoun H. Betteridge D. Durrington P. Hitman G. Neil H. Livingstone S. Charlton-Menys V. Fuller J.

Diabetologia, Vol. 50, Iss. 4, 2007-04 ,pp. : 733-740

Springer Publishing Company

Access to resources Recommend Favorite

Should Aspirin Be Used for the Primary Prevention of Cardiovascular Disease in the General Population?

Medical Principles and Practice, Vol. 24, Iss. 2, 2014-11 ,pp. : 198-198

Karger

Access to resources Recommend Favorite

Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980–2009: The Minnesota Heart Survey

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 12, 2015-12 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-Effectiveness of Antiretroviral Therapy for Prevention

Current HIV Research, Vol. 9, Iss. 6, 2011-09 ,pp. : 405-415

Bentham Science Publishers

Access to resources Recommend Favorite

Primary Prevention for Cardiovascular Diseases: Can Statins Replace Aspirin?

Medical Principles and Practice, Vol. 20, Iss. 6, 2011-10 ,pp. : 584-584

Karger

Access to resources Recommend Favorite